
Related Links
Understanding Cancer
American Cancer Society Guidelines for the Early Detection of Cancer
The following cancer screening guidelines are recommended for those people at average risk for cancer (unless otherwise specified) and without any specific symptoms.
People who are at increased risk for certain cancers may need to follow a different screening schedule, such as starting at an earlier age or being screened more often. Those with symptoms that could be related to cancer should see their doctor right away.
Cancer-related Checkup
For people age 20 or older having periodic health exams, a cancer-related
checkup should include health counseling, and depending on a person's age and
gender, might include exams for cancers of the thyroid, oral cavity, skin,
lymph nodes, testes and/or ovaries, as well as for some non-malignant (non-cancerous)
diseases.
Special tests for certain cancer sites are recommended as outlined below.
Breast Cancer
Colon and Rectal Cancer
Beginning at age 50, both men and women should follow one of these five testing
schedules:
*For FOBT, the take-home multiple sample method should be used.
**The combination
of yearly FOBT or FIT flexible sigmoidoscopy every five years is preferred over
either of these options alone.
All positive tests should be followed up with a colonoscopy. People should talk to their doctor about starting colorectal cancer screening earlier and/or undergoing screening more often if they have any of the following colorectal cancer risk factors:
Cervical Cancer
Endometrial (Uterine) Cancer
The American Cancer Society recommends that at the time
of menopause, all women should be informed about the risks and symptoms of
endometrial cancer, and strongly encouraged to report any unexpected bleeding
or spotting to their doctors. For women with high risk for hereditary
non-polyposis colon cancer (HNPCC), annual screening should be offered for
endometrial cancer with endometrial biopsy beginning at age 35. Learn
more about endometrial cancer.
Prostate Cancer
Both the prostate-specific antigen (PSA) blood test and digital rectal examination
(DRE) should be offered annually, beginning at age 50, to men who have at least
a 10-year life expectancy. Men at high risk (African-American men and men with
a strong family history of one or more first-degree relatives [father, brothers] diagnosed
before age 65) should begin testing at age 45. Men at even higher risk, due
to multiple first-degree relatives affected at an early age, could begin testing
at age 40. Depending on the results of this initial test, no further testing
might be needed until age 45.
Information should be provided to all men about what is known and what is uncertain about the benefits, limitations and dangers of early detection and treatment of prostate cancer so that they can make an informed decision about testing.
Men who ask their doctor to make the decision on their behalf should be tested. Discouraging testing is not appropriate. Also, not offering testing is not appropriate. Learn more about prostate cancer.